Skip to main content
Log in

MYELODYSPLASTIC NEOPLASM

Classification of rare pediatric myeloid neoplasia—Quo vadis?

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka H-M, et al. International Consensus Classification of myeloid neoplasms and acute leukemia: Integrating morphologic, clinical and genomic data. Blood 2022;140:1200–1228.

  2. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myloid and histocytic/dentritic neoplasms. Leukemia. 2022;36:1703–19.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Baumann I, Führer M, Behrend S, Campr V, Csomor J, Furlan I, et al. Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria. Histopathology. 2012;61:10–7.

    Article  PubMed  Google Scholar 

  4. Hasegawa D. The current perspective of low-grade myelodysplastic syndrome in children. Int J Hematol. 2016;103:360–4.

    Article  PubMed  Google Scholar 

  5. Niemeyer CM, Flotho C. Juvenile myelomonocytic leukemia: who’s the driver at the wheel? Blood. 2019;133:1060–70.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

CMN, MR, CF, AS and KRC wrote the manuscript. OW, HH, ES, BS, LAG, and AO reviewed the manuscript and provided critical edits. All authors read, commented on and approved the manuscript.

Corresponding author

Correspondence to Katherine R. Calvo.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Niemeyer, C.M., Rudelius, M., Shimamura, A. et al. Classification of rare pediatric myeloid neoplasia—Quo vadis?. Leukemia 36, 2947–2948 (2022). https://doi.org/10.1038/s41375-022-01731-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41375-022-01731-w

  • Springer Nature Limited

This article is cited by

Navigation